University of Montana Researchers Prep Fentanyl, Heroin Vaccines for Human Trials


Researchers at the University of Montana and their partners are nearing human trials for vaccines to prevent fentanyl and heroin drug overdoses.

The vaccines would protect people struggling with drug addiction or those at risk of accidental overdose. According to the National Institutes of Health, more than 106,000 U.S. drug overdose deaths were reported in 2021. Of those, 71,000 can be attributed to synthetic opioids like fentanyl.

Researcher Jay Evans directs the UM Center for Translational Medicine, which is working on the vaccines. He also is co-founder of Inimmune, the corporate partner charged with scaling up the vaccine components for manufacture. Inimmune is based in MonTEC, UM’s Missoula-based business incubator.


By Cary Shimek, UM News Service


News Catrgory Sponspor:

Montana Bioscience Cluster Initiative - Collaborative program design and execution and integrated programs fostering innovation, technology commercialization, entrepreneurship and sustainable small businesses

Leave a Comment

You must be logged in to post a comment.